TrialHaematologica2020

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.

Richard Aplenc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.